Radical prostatectomy versus watchful waiting in early prostate cancer
- PMID: 21542742
- DOI: 10.1056/NEJMoa1011967
Radical prostatectomy versus watchful waiting in early prostate cancer
Abstract
Background: In 2008, we reported that radical prostatectomy, as compared with watchful waiting, reduces the rate of death from prostate cancer. After an additional 3 years of follow-up, we now report estimated 15-year results.
Methods: From October 1989 through February 1999, we randomly assigned 695 men with early prostate cancer to watchful waiting or radical prostatectomy. Follow-up was complete through December 2009, with histopathological review of biopsy and radical-prostatectomy specimens and blinded evaluation of causes of death. Relative risks, with 95% confidence intervals, were estimated with the use of a Cox proportional-hazards model.
Results: During a median of 12.8 years, 166 of the 347 men in the radical-prostatectomy group and 201 of the 348 in the watchful-waiting group died (P=0.007). In the case of 55 men assigned to surgery and 81 men assigned to watchful waiting, death was due to prostate cancer. This yielded a cumulative incidence of death from prostate cancer at 15 years of 14.6% and 20.7%, respectively (a difference of 6.1 percentage points; 95% confidence interval [CI], 0.2 to 12.0), and a relative risk with surgery of 0.62 (95% CI, 0.44 to 0.87; P=0.01). The survival benefit was similar before and after 9 years of follow-up, was observed also among men with low-risk prostate cancer, and was confined to men younger than 65 years of age. The number needed to treat to avert one death was 15 overall and 7 for men younger than 65 years of age. Among men who underwent radical prostatectomy, those with extracapsular tumor growth had a risk of death from prostate cancer that was 7 times that of men without extracapsular tumor growth (relative risk, 6.9; 95% CI, 2.6 to 18.4).
Conclusions: Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer. Men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment. (Funded by the Swedish Cancer Society and the National Institutes of Health.).
Comment in
-
Effective treatment for early-stage prostate cancer--possible, necessary, or both?N Engl J Med. 2011 May 5;364(18):1770-2. doi: 10.1056/NEJMe1100787. N Engl J Med. 2011. PMID: 21542749 No abstract available.
-
Surgical oncology: Good things don't come to those who watchfully wait.Nat Rev Clin Oncol. 2011 Jun 7;8(7):386. doi: 10.1038/nrclinonc.2011.84. Nat Rev Clin Oncol. 2011. PMID: 21647197 No abstract available.
-
ACP Journal Club. Radical prostatectomy reduced mortality and disease progression over the long term more than watchful waiting in early prostate cancer.Ann Intern Med. 2011 Jul 19;155(2):JC1-2. doi: 10.7326/0003-4819-155-2-201107190-02002. Ann Intern Med. 2011. PMID: 21768568 No abstract available.
-
Early prostate cancer--treat or watch?N Engl J Med. 2011 Aug 11;365(6):569. doi: 10.1056/NEJMc1106325. N Engl J Med. 2011. PMID: 21830972 No abstract available.
-
Early prostate cancer--treat or watch?N Engl J Med. 2011 Aug 11;365(6):568-9. doi: 10.1056/NEJMc1106325. N Engl J Med. 2011. PMID: 21830973 No abstract available.
-
Early prostate cancer--treat or watch?N Engl J Med. 2011 Aug 11;365(6):568. doi: 10.1056/NEJMc1106325. N Engl J Med. 2011. PMID: 21830974 No abstract available.
-
Randomised trial of radical prostatectomy versus watchful waiting finds reduced risk for death but uncertainty still reigns.Evid Based Med. 2012 Apr;17(2):38-9. doi: 10.1136/ebm.2011.100101. Epub 2011 Aug 23. Evid Based Med. 2012. PMID: 21865231 No abstract available.
-
[What is the influence of local treatment on overall survival in early prostate cancer?].Strahlenther Onkol. 2012 May;188(5):442-3. doi: 10.1007/s00066-012-0090-7. Strahlenther Onkol. 2012. PMID: 22410837 German. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical